PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 114 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2015. The put-call ratio across all filers is 686.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,000 | 0.0% | 3,419 | -27.5% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 4,719 | +125.3% | 0.00% | – |
| Q1 2016 | $2,000 | -85.7% | 2,095 | -54.0% | 0.00% | -100.0% |
| Q3 2015 | $14,000 | -44.0% | 4,558 | +5.3% | 0.00% | -50.0% |
| Q2 2015 | $25,000 | -77.1% | 4,328 | -62.8% | 0.00% | -84.6% |
| Q4 2014 | $109,000 | – | 11,636 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,010,000 | $905,000 | 0.21% |
| GLOBEFLEX CAPITAL L P | 226,959 | $102,000 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 62,800 | $28,000 | 0.01% |
| MENTA CAPITAL LLC | 195,136 | $87,000 | 0.01% |
| Orbimed Advisors | 1,073,000 | $481,000 | 0.01% |
| GOODWIN DANIEL L | 22,679 | $10,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 215,800 | $97,000 | 0.00% |
| Renaissance Technologies | 2,214,396 | $992,000 | 0.00% |
| STOCK YARDS BANK & TRUST CO | 30,170 | $14,000 | 0.00% |
| HIGHLAND CAPITAL MANAGEMENT, LLC | 41,000 | $18,000 | 0.00% |